Antiviral Treatment for Congenital Cytomegalovirus Infection in Extremely Preterm Newborn: A Case Report and Literature Review

20260 citationsJournal Articlegold Open Access

Authors

Giovanni Boscarino · University of Parma

Giusy Davino · University of Parma

Silvia Pezzoni · University of Parma

Mara Corradi · University of Parma

Maria Carmela Pera · University of Parma

Susanna Esposito · University of Parma

Enzo Romanini ·

Abstract

Antiviral therapy for cCMV infection with ganciclovir and valgancyclovir in premature neonates is feasible and safe with careful monitoring, and appears to provide benefits. Nevertheless, well-designed studies that include pharmacokinetics and pharmacodynamics, virologic monitoring, and long term outcomes of development, vision and hearing are urgently needed.

Topics & Keywords

Cytomegalovirus and herpesvirus research Neonatal and fetal brain pathology Neonatal Health and Biochemistry

UN Sustainable Development Goals

No poverty

Publication Details

Published in: Viruses

Volume 18, Issue 3, pp. 391-391

DOI: 10.3390/v18030391

Field-Weighted Citation Impact: 0.00